top of page
The Professional Network for Healthcare Experts
China approves Bio-Thera's Ashuli as its first golimumab biosimilar
Bio-Thera has secured Chinese regulatory approval for Ashuli, the country's first golimumab biosimilar, expanding domestic biosimilar competition in rheumatoid arthritis and ankylosing spondylitis.
nuaxia
23 hours ago2 min read
NMPA Approves Ecnoglutide for Chronic Weight Management in Adults with Overweight or Obesity
China authorises the first cAMP-biased GLP-1 receptor agonist for obesity, following robust Phase III SLIMMER trial results.
nuaxia
Mar 91 min read
bottom of page